Streetbeat News

Stock Prices

GOOGL

Deep-pocketed investors are showing unusual bearish options activity towards Alphabet (NASDAQ:GOOGL), with 57% of the options being bearish. This suggests potential significant market movements. Analysts have mixed ratings, with price targets ranging from $182 to $220.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 3:00 pm

AMD

The article provides a comprehensive evaluation of Advanced Micro Devices (AMD) in comparison to its peers in the Semiconductors & Semiconductor Equipment industry. AMD's high P/E ratio suggests overvaluation, while its low P/B and P/S ratios indicate potential undervaluation. The company lags behind peers in ROE, EBITDA, gross profit, and revenue growth, but maintains a strong financial position with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 3:00 pm

ACTV

PSCC

THS

TreeHouse Foods, Inc. (NYSE:THS) shares are trading slightly lower due to a voluntary recall of specific frozen waffle products over potential Listeria contamination. No illnesses have been reported, and the recall is in cooperation with the FDA and CFIA. THS stock has gained 0.6% over the past year.

Portfolio Pulse from Nabaparna Bhattacharya

October 18, 2024 | 3:00 pm

OHI

Omega Healthcare Invts (NYSE:OHI) has been analyzed by 5 analysts, showing a range of opinions from bullish to indifferent. Recent ratings indicate a positive trend with a 12.53% increase in the average 12-month price target. Analysts have raised their price targets, reflecting optimism about the company's future performance. Omega Healthcare Invts is a healthcare facility REIT with strong financial metrics, including a high net margin and efficient debt management.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 3:00 pm

V

The article provides a comprehensive analysis of Visa (NYSE:V) compared to its competitors in the Financial Services industry. Visa shows potential undervaluation with a lower P/E ratio but appears overvalued in terms of P/B and P/S ratios. It demonstrates high profitability and operational efficiency with strong ROE, EBITDA, and gross profit, but its revenue growth lags behind the industry average.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 3:00 pm

LLY

Eli Lilly (NYSE:LLY) is evaluated against its competitors in the Pharmaceuticals industry. The company shows high valuation metrics (P/E, P/B, P/S) compared to industry averages, suggesting potential overvaluation. However, it demonstrates strong revenue growth and ROE, indicating robust performance. Concerns arise from lower EBITDA and gross profit, which may affect operational efficiency.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 3:00 pm

DOGEUSD

Dogecoin's price has surged by 11.79% in the last 24 hours, continuing a positive trend with a 23% gain over the past week. Trading volume has increased by 271%, while the circulating supply slightly decreased. Dogecoin's market cap is ranked #9 at $19.88 billion.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 3:00 pm

AG

First Majestic Silver shares are experiencing an upward trend following HC Wainwright & Co.'s decision to reiterate a Buy rating on the stock.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 2:56 pm

DRUG

Bright Minds Biosciences experienced a significant stock price surge, with shares initially resuming trade and then being halted due to a circuit breaker as the stock rose by 186.2%.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 2:56 pm

CCK

Crown Holdings shares rose as the company reported Q3 adjusted EPS results that exceeded expectations and provided FY24 EPS guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 2:54 pm